Ultralife Corporation - Common Stock (NQ:ULBI)
Price and Volume
Detailed Quote| Volume | 19,815 |
| Open | 6.780 |
| Bid (Size) | 6.300 (300) |
| Ask (Size) | 7.000 (500) |
| Prev. Close | 6.780 |
| Today's Range | 6.390 - 6.860 |
| 52wk Range | 4.900 - 8.250 |
| Shares Outstanding | 16,466,594 |
| Dividend Yield | N/A |
Top News
More News
Ultralife Q2 Earnings Call Highlights ↗
August 07, 2026
Via MarketBeat
Performance
52-Week Range
21.1% below 52-week high
6.510
4.9052W Low
8.2552W High
1 Week
6.1% below 1-week high
6.001W Low
6.931W High
Ultralife Corporation - Common Stock (ULBI) traded between $4.90 and $8.25 over the past 52 weeks and last traded at $6.51, 21.1% below its 52-week high. Over the past week it ranged between $6.00 and $6.93.
Past 12 Months
+7.6%
+5.2%
+6.5%
-3.4%
+15.2%
-4.4%
1W
+$0.46
1M
+$0.32
3M
+$0.40
6M
-$0.23
YTD
+$0.86
1Y
-$0.30
ULBI was -4.4% over the past year, -3.4% over six months, +15.2% year to date, +7.6% in the last week.
12 Months vs Market
ULBI
-4.4%
DIA
+9.9%
SPY
+15.0%
QQQ
+23.7%
IWM
+15.4%
Over the past 12 months ULBI returned -4.4% versus DIA (Dow) +9.9%, SPY (S&P 500) +15.0%, QQQ (Nasdaq 100) +23.7% and IWM (Russell 2000) +15.4%.
Volume & Liquidity
0.48× 3-mo avg
Today 19,815
3-mo avg 41.0K
1W
49.6K
1M
44.8K
3M
41.0K
6M
41.1K
YTD
44.0K
1Y
45.1K
ULBI most recently traded 19,815 shares against a 3-month average daily volume of 41.0K.
More News
Read More
Ultralife (ULBI) Q1 2026 Earnings Transcript ↗
June 01, 2026
Via The Motley Fool
Topics
World Trade
Earnings Scheduled For August 7, 2025 ↗
August 07, 2025
Via Benzinga
Ultralife Q1 Earnings Call Highlights ↗
May 09, 2026
Via MarketBeat
Topics
Earnings
Earnings Scheduled For November 18, 2025 ↗
November 18, 2025
Via Benzinga
Earnings Preview For Ultralife ↗
November 17, 2025
Via Benzinga
12 Industrials Stocks Moving In Tuesday's After-Market Session ↗
November 11, 2025
Via Benzinga
12 Industrials Stocks Moving In Friday's Pre-Market Session ↗
October 17, 2025
Via Benzinga
Ultralife (ULBI) Q2 Revenue Rises 13% ↗
August 07, 2025
Via The Motley Fool
Topics
Economy
Ultralife (ULBI) Q2 2025 Earnings Call Transcript ↗
August 07, 2025
Via The Motley Fool
12 Industrials Stocks Moving In Thursday's Intraday Session ↗
August 07, 2025
Via Benzinga
Discover the top movers in Thursday's pre-market session. ↗
August 07, 2025
Via Chartmill
12 Industrials Stocks Moving In Thursday's Pre-Market Session ↗
August 07, 2025
Via Benzinga
Via Benzinga
Earnings Scheduled For May 9, 2025 ↗
May 09, 2025
Via Benzinga
Examining the Future: Ultralife's Earnings Outlook ↗
May 08, 2025
Via Benzinga
Via Benzinga
Ultralife Stock Pares Some Losses Following Q4 Profit Miss, Retail Banks On Future Growth ↗
April 02, 2025
Via Stocktwits
Topics
Earnings
Via Benzinga
Frequently Asked Questions
Is Ultralife Corporation - Common Stock publicly traded?
Yes, Ultralife Corporation - Common Stock is publicly traded.
What exchange does Ultralife Corporation - Common Stock trade on?
Ultralife Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Ultralife Corporation - Common Stock?
The ticker symbol for Ultralife Corporation - Common Stock is ULBI on the Nasdaq Stock Market
What is the current price of Ultralife Corporation - Common Stock?
The current price of Ultralife Corporation - Common Stock is 6.510
When was Ultralife Corporation - Common Stock last traded?
The last trade of Ultralife Corporation - Common Stock was at 10/02/26 04:00 PM ET
What is the market capitalization of Ultralife Corporation - Common Stock?
The market capitalization of Ultralife Corporation - Common Stock is 107.20M
How many shares of Ultralife Corporation - Common Stock are outstanding?
Ultralife Corporation - Common Stock has 107M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>